Megadalton Solutions Inc

Bloomington, IN · Medtech · Acquired

Charge detection mass spectrometry (CDMS) instrument for analyzing gene therapy viral vectors

Claim this profile

Follows are private to you and power your alerts

Updated · megadaltonsolutions.com

Sector
Medtech
Headquarters
Bloomington, IN
Total capital
$3M
Federal grants
$3M
6 awards · 2019–2024
Rank in peer group#53 of 79
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $3M$150K$150K$790K$1.2M$398K$294K
201920202021202220232024FEDERAL ↑EQUITY ↓Cumulative $3M$790K$1.2M$398K$294K

Latest events

  • Federal grantHealth and Human S · Phase I · Multi-detector Array CD-MS for Rapid Analysis of Very High Mass Analytes$294K
  • Federal grantHealth and Human S · Phase II · Development of a charge detection mass spectrometer for the analysis ofgene therapy and other large pharmaceutical biologics$398K
  • Federal grantHealth and Human S · Phase II · Development of a charge detection mass spectrometer for the analysis ofgene therapy and other large pharmaceutical biologics$1.2M
  • Federal grantHealth and Human S · Phase II · Development of a charge detection mass spectrometer for the analysis ofgene therapy and other large pharmaceutical biologics$790K
  • Federal grantHealth and Human S · Phase I · Developing a commercial charge detection mass spectrometer for MDa to GDa mass measurements$150K
  • Federal grantHealth and Human S · Phase I · Developing a commercial charge detection mass spectrometer for MDa to GDa mass measurements$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 79 peers

Line = median

Medtech · Instrument

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 3
  • PendingSystem And Method For Simultaneous Analysis Of Multiple Charged Particles With A Charge Detection Mass SpectrometerUSPTOApplication 18960229
  • PendingSystem And Method For Simultaneous Analysis Of Multiple Charged Particles With A Charge Detection Mass SpectrometerUSPTOApplication 63651607
  • PendingSystem And Method For Simultaneous Analysis Of Multiple Charged Particles With A Charge Detection Mass SpectrometerUSPTOApplication 63605025

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .